William Blair
http://www.williamblair.comWilliam Blair & Company, L.L.C. is a Chicago-based investment firm offering investment banking, asset management, equity research, institutional and private brokerage, and private capital to individual, institutional, and issuing clients. Since 1935, it has been committed to helping clients achieve their financial objectives.
View Older Stories View More Recent Stories
-
Grid Dynamics to Participate in Virtual Non-Deal Roadshows with JP Morgan and William Blair
-
William Blair Reiterates Outperform Rating on Kinnate Biopharma (KNTE), Sees Potential for Significant Upside in Shares
-
PRO Unlimited to Acquire Geometric Results, Inc., a Leading Managed Services Provider
-
William Blair Reiterates Outperform Rating on Eagle Pharmaceuticals (EGRX), Sees Multiple Possibilities for Further Upside
-
Berkshire Partners and Warburg Pincus to partner for an investment in Ensemble Health Partners
-
Berkshire Partners and Warburg Pincus to partner for an investment in Ensemble Health Partners
-
Eagle Pharmaceuticals (EGRX) to Acquire Acacia Pharma Group for EUR 94.7M
-
Eagle Pharmaceuticals Agrees to Terms to Acquire Acacia Pharma Group plc
-
Offer by Eagle Pharmaceuticals, Inc.
-
Form D WILLIAM BLAIR MB INVESTM
-
William Blair Reiterates Outperform Rating on 9 Meter Biopharma (NMTR), Shares Have Assymetric Risk/Reward
-
Form 24F-2NT WILLIAM BLAIR FUNDS For: Dec 31
-
Forge Global, Inc. and Motive Capital Corp Announce Closing of Business Combination to Create the First Publicly Traded Private Securities Marketplace
-
Form 24F-2NT WILLIAM BLAIR FUNDS For: Oct 31
-
Form D WILLIAM BLAIR MB INVESTM
-
Form D WILLIAM BLAIR MB INVESTM
-
William Blair Investment Management Introduces Mid Cap Value Fund
-
Reaction Biology Announces Closing of Growth Investment from Cobepa and Chief Executive Officer Transition
-
Shift (SFT) Acquires Fair’s Dealer Listing Marketplace Technology
-
Shift to Acquire Fair’s Dealer Listing Marketplace Technology, Team to Expand E-commerce Auto Platform; SoftBank Group to Fully Fund Acquisition
-
Shift to Acquire Fair’s Dealer Listing Marketplace Technology, Team to Expand E-commerce Auto Platform; SoftBank Group to Fully Fund Acquisition
-
Form D/A William Blair China A-Sh
-
William Blair Reiterates Brickell Biotech (BBI) at Outperform, Sees "Strong Risk/Reward Profile" at Current Valuations
-
Form N-CEN WILLIAM BLAIR FUNDS For: Dec 31
-
PowerSchool Holdings Inc. (PWSC) NDR Takeaways - William Blair
-
VSE Corporation's (VSEC) New 737 Airline Partnership Should Generate Long-Term Returns - William Blair
-
William Blair Reiterates Docusign (DOCU) at Outperform, Sales Restructuring is Concerning, but Company has Large Market Opportunity and Enjoys Strong Secular Growth Trends
-
Green Thumb Industries Announces Departure of Wes Moore from Board of Directors
-
Green Thumb Industries Announces Departure of Wes Moore from Board of Directors
-
William Blair Reiterates Outperform Rating on Vertex Inc. (VERX), Results Illustrate Underlying Business Trends Continue to Improve
-
GE's investors look for update on supply-chain, inflationary pressures
-
Lyra Therapeutics (LYRA) Reiterated at Outperform by William Blair, Company Poised to Become a Major Player, Significant Disconnect in Valuation Exists, Remains Favorite Small-Cap Name,
-
Sachem Capital Corp. Announces Closing of Public Offering of $50.0 Million of 6.00% Notes
-
Banks in talks with distressed buyers on Russian assets - sources
-
William Blair Reiterates Revance Therapeutic (RVNC) at Outperform, Sees DAXI as a Blockbuster in the Making, Believes Approval is an Eventuality
-
UPDATE: William Blair Starts Brickell Biotech Inc. (BBI) at Outperform
-
Currencies Direct Announces £140 Million Strategic Investment from Blackstone
-
AmeriVet Veterinary Partners Acquired by AEA Investors LP and ADIA From Imperial Capital
-
UPDATE: William Blair Starts BRC Inc. (BRCC) at Outperform
-
Similarweb Ltd (SMWB) Management Meetings Convey Bullish Tone on Growth - William Blair
-
Form 497J WILLIAM BLAIR FUNDS
-
Stuck but not sweating it: some U.S. investors in Russia not kneejerk-selling
-
Sachem Capital Corp. Prices Registered Public Offering of $50.0 Million of 6.00% Notes
-
Sachem Capital Corp. Announces Registered Public Offering of Notes
-
ForgeRock to Present at Upcoming Investor Conferences
-
Allscripts (MDRX) to Sell the Net Assets of Its Hospitals & Large Physician Practices Business Segment to Constellation Software
-
Allscripts to Sell the Net Assets of Its Hospitals & Large Physician Practices Business Segment to Constellation Software
-
Analysis-Ukraine war raises spectre of Russia's first external debt default
-
Lightspeed Systems Receives Strategic Growth Investment from Genstar Capital
-
William Blair Reiterates Market Perform Rating on Allakos (ALLK), Believes lirentelimab May Ultimately Be Approved but Warns of Protracted Timelines and Additional Costs

